The heart failure revascularisation trial (HEART)

European Journal of Heart Failure

Volumn 13, Issue 2, 2011, Pages 227-233

  Cleland, John G F ^a   Calvert, Melanie ^b   Freemantle, Nick ^b   Arrow, Yvonne ^a   Ball, Stephen G ^c   Bonser, Robert S ^d   Chattopadhyay, Sudipta ^a   Norell, Michael S ^e   Pennell, Dudley J ^f   Senior, Roxy ^g  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e NEW CROSS HOSPITAL   (United Kingdom)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Heart failure; Mortality; Myocardial viability; Randomized controlled trial

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT VENTRICLE SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC DYSFUNCTION;

AGED; ANGINA PECTORIS; ANGIOPLASTY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79551473380     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq230     Document Type: Article

References (16)

1. Pitt M, Lewis ME, Bonser RS. Coronary artery surgery for ischemic heart failure: risks, benefits, and the importance of assessment of myocardial viability. Prog Cardiovasc Dis 2001;43:373-386.
2. Cleland JGF, Freemantle N, Ball SG, Bonser RS, Camici P, Chattopadhyay S, Dutka D, Eastaugh J, Hampton J, Large S, Norell MS, Pennell DJ, Pepper J, Sanda S, Senior R, Smith D. The heart failure revascularization trial (HEART): rationale design and methodology. Eur J Heart Fail 2003;5:295-303.
3. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. New Engl J Med 1985;312:1665-1671.
4. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39: 1151-1158.
5. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
6. Cleland JGF, Pennell DJ, Ray S, Murray G, Macfarlane P, Cowley A, Coats A, Lahiri A, The CHRISTMAS study steering committee and investigators. The Car-vedilol Hibernation Reversible Ischaemia Trial: marker of success (CHRISTMAS). Eur J Heart Fail 1999;1:191-196.
7. Cleland JGF, Pennell DJ, Ray SG, Coats A, McFarlane P, Murray G, Mule JD, Vered Z, Lahiri A, CHRISTMAS Investigators. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet 2003;362:14-21.
8. Testa L, Van Gaal WJ, Biondi Zoccai GG, Agastoni P, Latini RA, Bedogni F, Porto I, Banning AP. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM 2009;102:369-378.
9. Rahimi K, Banning AP, Cheng AS, Pegg TJ, Karamitsos TD, Channon KM, Darby S, Taggart DP, Neubauer S, Selvanayagam JB. Prognostic value of coronary revascu-larisation related myocardial injury: a cardiac magnetic resonance imaging study. Heart 2009;95:1937-1943.
10. Sparrow P, Loh PH, Nikitin N, Cleland JG, Ball SG, Plein S. Chronically ischaemic hibernating myocardium reduces prediction of recovery by delayed enhancement cardiac magnetic resonance imaging in heart failure secondary to coronary disease with no symptoms of angina [abstract 155]. Heart 2008;94 (Supplement II):A84.
11. Shih JH. Sample size calculation for complex clinical trials with survival endpoints. Control Clin Trials 1995;16:395-407.
12. Velazquez EJ, Lee KL, O'Connor CM, Oh JK, Bonow RO, Pohost GM, Feldman AM, Mark DB, Panza JA, Sopko G, Rouleau JL, Jones RH, STICH Investigators. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2007;134:1540-1547.
13. Cleland JGF. Is aspirin 'The Weakest Link' in cardiovascular prophylaxis. The surprising lack of evidence supporting the use of aspirin for cardiovascular disease. Prog Cardiovasc Dis 2002;44:275-292.
14. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Janosi A, Kamensky G, Konajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, Van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, CORONA group. Rosuvastatin in older patients with systolic heart failure. New Engl J Med 2007;357:2248-2261. (Pubitemid 350190755)
15. Mitropoulos FA, Elefteriades JA. Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction. Heart Fail Rev 2001;6:163-175.
16. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira H, Moiseyev VS, Preda I, Van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J. The EuroHeart Failure survey programme: survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:422-463.